Skip to main content

Table 1 Baseline characteristics of 1327 patients with CHF and CKD

From: Inferior vena cava diameter in patients with chronic heart failure and chronic kidney disease: a retrospective study

Baseline characteristics

Overall (n = 1327)

Normal IVC (n = 1167)

Abnormal IVC (n = 160)

p value

Demography

 Age

72.30 (61.89, 80.73)

72.67 (62.45, 81.21)

67.36 (58.60, 77.25)

 < 0.001

 Male

839 (63.2)

731 (62.6)

108 (67.5)

0.001

 SBP

135.00 (120.00, 151.00)

136.00 (120.00, 152.00)

130.00 (115.00, 149.00)

0.281

 DBP

73.00 (64.50, 83.00)

73.00 (65.00, 84.00)

74.00 (63.00, 83.00)

0.001

 HR

79.00 (70.00, 92.00)

79.00 (70.00, 92.00)

80.00 (69.00, 91.00)

0.563

 BMI

24.67 (22.16, 27.06)

24.63 (22.10, 27.05)

24.80 (22.64, 27.70)

0.176

Laboratory tests

 NT-proBNP

5416.00 (2,049.50, 14,595.00)

4897.00 (1,899.00, 14,175.50)

8220.00 (3,895.00, 20,160.50)

 < 0.001

 Hemoglobin

119.00 (100.00, 136.00)

120.00 (101.00, 136.00)

116.00 (95.00, 136.50)

0.154

 White blood cells

6.85 (5.53, 8.61)

6.90 (5.62, 8.61)

6.41 (4.85, 8.61)

0.02

 Total protein

68.30 (64.12, 72.88)

68.30 (64.20, 72.97)

68.05 (62.18, 72.58)

0.177

 Serum albumin

38.20 (34.85, 41.10)

38.30 (35.00, 41.20)

37.65 (33.60, 40.18)

0.026

 FBG

5.56 (4.82, 7.21)

5.59 (4.85, 7.32)

5.36 (4.63, 6.58)

0.015

 Serum creatine

143.30 (118.60, 214.15)

141.10 (117.65, 213.50)

156.95 (124.47, 228.20)

0.034

 eGFR

41.48 (24.64, 52.46)

41.84 (24.64, 52.71)

39.47 (24.81, 50.61)

0.184

 Uric acid

455.75 (378.05, 560.28)

445.15 (369.33, 543.78)

565.90 (475.82, 650.45)

 < 0.001

 Urinary albumin

20.00 (0.00, 75.00)

20.00 (0.00, 100.00)

20.00 (0.00, 70.00)

0.453

Comorbidities

 MI

566 (42.7)

532 (45.6)

34 (21.2)

 < 0.001

 Hypertension

1064 (80.2)

955 (81.8)

109 (68.1)

 < 0.001

 DM

710 (53.5)

639 (54.8)

71 (44.4)

0.017

 Anemia

801 (60.4)

702 (60.2)

99 (61.9)

0.741

Treatment

 PCI

313 (23.6)

299 (25.6)

14 (8.8)

 < 0.001

 CABG

62 (4.7)

57 (4.9)

5 (3.1)

0.43

 Heart valve replacement

28 (2.1)

14 (1.2)

14 (8.8)

 < 0.001

 Heart pacemaker implantation

93 (7.0)

75 (6.4)

18 (11.2)

0.038

 Defibrillator

9 (0.7)

5 (0.4)

4 (2.5)

0.013

 Statin

1017(76.6)

930 (79.7)

87 (54.4)

 < 0.001

 ACEI

438 (33.0)

377 (32.3)

61 (38.1)

0.168

 ARB

429 (32.3)

381 (32.6)

48 (30.0)

0.561

 Beta blocker

1129 (85.1)

1004 (86.0)

125 (78.1)

0.012

 Loop diuretic

1167 (87.9)

1012 (86.7)

155 (96.9)

 < 0.001

 Potassium-sparing diuretic

961 (72.4)

829 (71.0)

132 (82.5)

0.003

 Warfarin

166 (12.5)

123 (10.5)

43 (26.9)

 < 0.001

  1. Nonabnormal continuous values were showed as median (IQR) and categorical values were showed as number (%). SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, BMI Body mass index, eGFR estimated glomerular filtration rate, FBG fasting blood glucose, MI myocardial infarction, DM diabetes, PCI percutaneous coronary intervention, CABG coronary artery bypass graft, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker; Statin 1, ACEI 1, ARB 1, beta blocker 1, loop diuretic 1 and potassium-sparing diuretic 1, warfarin 1 refers medication used during hospitalization, and Statin 2, ACEI 2, ARB 2, beta blocker 2, loop diuretic 2 and potassium-sparing diuretic 2, warfarin 2 refers medication used after discharge